MedTrace Logo

The Relationship Between CES1 Genotype and Methylphenidate Response in Children With ADHD - INDICES Work Package 6

NCT04366609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2020-04-29

No results posted yet for this study

Summary

This is a prospective observational study of a cohort of children diagnosed with Attention Deficit Hyperactive Disorder (ADHD) and followed with weekly assessments during the first 12 weeks of Methylphenidate (MPH) treatment, and after three years.

The overall aim is to gain knowledge in order to develop guidelines for more individualized treatments with (MPH), obtain a better drug response, and reduce the risk of adverse reactions, in order to improve adherence and long-term outcome.

Conditions

  • ADHD

Interventions

DRUG

Methylphenidate

Treatment with methylphenidate through dose escalation

Sponsors & Collaborators

  • Copenhagen University Hospital, Denmark

    collaborator OTHER

  • Mental Health Services in the Capital Region, Denmark

    lead OTHER

Principal Investigators

  • Pia Jeppesen, PhD, MD · Mental Health Services in the Capital Region, Denmark

  • Tine B Houmann, MD · Mental Health Services in the Capital Region, Denmark

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-01
Primary Completion
2014-08-01
Completion
2017-11-01
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366609 on ClinicalTrials.gov